Shares of Albemarle Co. (NYSE:ALB) have received an average rating of “Buy” from the twenty-four brokerages that are presently covering the firm, MarketBeat reports. Ten analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $125.75.
Several equities research analysts have recently weighed in on the company. UBS Group increased their price objective on Albemarle from $123.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, November 9th. Jefferies Group reissued a “buy” rating on shares of Albemarle in a report on Tuesday, October 24th. BMO Capital Markets assumed coverage on Albemarle in a report on Tuesday, October 24th. They issued an “outperform” rating and a $160.00 price objective for the company. Zacks Investment Research downgraded Albemarle from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Finally, Loop Capital set a $150.00 price objective on Albemarle and gave the company a “buy” rating in a report on Tuesday, December 19th.
A number of institutional investors have recently added to or reduced their stakes in the business. William Blair Investment Management LLC lifted its holdings in Albemarle by 13.7% in the fourth quarter. William Blair Investment Management LLC now owns 31,709 shares of the specialty chemicals company’s stock valued at $4,055,000 after acquiring an additional 3,828 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Albemarle by 62.7% in the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 5,971 shares of the specialty chemicals company’s stock valued at $764,000 after buying an additional 2,300 shares in the last quarter. WealthPLAN Partners LLC purchased a new position in shares of Albemarle in the fourth quarter valued at $1,598,000. Slow Capital Inc. purchased a new position in shares of Albemarle in the fourth quarter valued at $898,000. Finally, Banco de Sabadell S.A purchased a new position in shares of Albemarle in the fourth quarter valued at $133,000. 87.23% of the stock is owned by institutional investors.
Albemarle (NYSE ALB) traded up $2.53 during mid-day trading on Tuesday, hitting $114.77. The stock had a trading volume of 430,176 shares, compared to its average volume of 2,470,000. The firm has a market capitalization of $12,680.00, a P/E ratio of 40.99, a P/E/G ratio of 1.48 and a beta of 1.56. Albemarle has a 1-year low of $91.02 and a 1-year high of $144.99. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56.
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.